Projects and Grants per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Residency, Washington University
1992
Doctor of Medicine, University Of Kentucky
1988
Bachelor of Arts, Berea College
1984
Fingerprint
Dive into the research topics where Daniel Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
-
SBIR: Cutaneous Phosphorylated Alpha-Synuclein for Detection of Prodromal Synucleinopathies
Lee, D. (PI)
9/15/22 → 8/31/25
Project: Research project
-
SBIR: Cutaneous Phosphorylated Alpha-Synuclein for Detection of Prodromal Synucleinopathies
Lee, D. (PI)
9/15/22 → 9/15/22
Project: Research project
-
7-AVP-786-205: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (deudextromethorphan hydrobromide [d6- DM]/quinidine sulfate [Q]) for the Treatment of Neurobehavioral Di
Lee, D. (PI)
7/10/20 → 11/30/22
Project: Research project
-
Efficacy of gabapentin enacarbil in adult patients with severe primary restless legs syndrome
Lee, D. O., Buchfuhrer, M. J., Garcia-Borreguero, D., Avidan, A. Y., Ahmed, M., Hays, R., Ondo, W. G., Jaros, M. J., Kim, R. & Shang, G., Mar 1 2016, In: Sleep Medicine. 19, p. 50-56 7 p.Research output: Contribution to journal › Article › peer-review
-
The Effect of Gabapentin Enacarbil on Quality of Life and Mood Outcomes in a Pooled Population of Adult Patients with Moderate-to-Severe Primary Restless Legs Syndrome
Avidan, A. Y., Lee, D., Park, M., Jaros, M. J., Shang, G. & Kim, R., Apr 1 2016, In: CNS Drugs. 30, 4, p. 305-316 12 p.Research output: Contribution to journal › Article › peer-review
-
Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbil
Bogan, R. K., Lee, D. O., Buchfuhrer, M. J., Jaros, M. J., Kim, R. & Shang, G., May 1 2015, In: Annals of Medicine. 47, 3, p. 269-277 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome
Lee, D. O., Ziman, R. B., Perkins, A. T., Poceta, J. S., Walters, A. S., Barrett, R. W., Arguello, F. J., Ball, E. M., Cohen, L., Drass, M. J., Duntley, S., Feller, M. D., Ferencz, G. J., Fisher, M. A., Garrison, J. E., Huddlestone, J. R., LeDoux, M. S., Lesh, K. W., Lorch, D. G. & Menn, S. J. & 9 others, , Jun 15 2011, In: Journal of Clinical Sleep Medicine. 7, 3, p. 282-292 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Personality correlates of adherence with continuous positive airway pressure (CPAP)
Moran, A. M., Everhart, D. E., Davis, C. E., Wuensch, K. L., Lee, D. O. & Demaree, H. A., Dec 2011, In: Sleep and Breathing. 15, 4, p. 687-694 8 p.Research output: Contribution to journal › Article › peer-review
Prizes
-
Edward N. and Della L. Thome Memorial Foundation Awards Program in Alzheimer’s Disease Drug Discovery Research
Lee, D. (Recipient), 2021
Prize: Honorary award